Qingdao Vland Biotech INC. (SHA:603739)

SHA:603739 Revenue

Qingdao Vland Biotech INC. had revenue of 345.05M CNY in the quarter ending March 31, 2026, with 11.24% growth. This brings the company's revenue in the last twelve months to 1.40B, up 4.23% year-over-year. In the year 2025, Qingdao Vland Biotech INC. had annual revenue of 1.37B with 3.43% growth.

• Revenue (ttm): 1.40B
• Revenue Growth: +4.23%
• P/S Ratio: 2.66
• Revenue / Employee: 912.69K
• Employees: 1,535
• Market Cap: 3.73B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.37B	45.36M	3.43%
Dec 31, 2024	1.32B	121.86M	10.16%
Dec 31, 2023	1.20B	35.74M	3.07%
Dec 31, 2022	1.16B	12.34M	1.07%
Dec 31, 2021	1.15B	190.57M	19.85%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 12, 2026

Data Sources Report a data error